Viagen Biotech Inc

Amgen is a leading human therapeutics company in the biotechnology industry. Since 1980, the company has tapped the power of scientific discovery and innovation to improve people s lives. Products include Aranesp, Enbrel, EPOGEN, Kepivance, Kineret, Neulasta, NEUPOGEN and Sensipar. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry s first blockbuster medicines. As a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness. The company, which trades on NASDAQ under the ticker symbol AMGN, has a location in Thousand Oaks, Calif.

Skye Orthobiologics, based in El Segundo, CA, specializes in the development and commercialization of innovative biologic allografts for various clinical applications, including advanced wound care and ocular products. The company emphasizes strong physician collaboration and has established a patient registry of over 5,000 individuals to demonstrate the safety and efficacy of its offerings. With a commitment to enhancing patient care, Skye partners with independent sales representatives and distributors to ensure widespread access to its biologic products across the U.S. and internationally. The company also provides comprehensive support, including product training and marketing tools, to facilitate the successful integration of its solutions into medical practice. Generated from the website

GeneTex focuses on antibody manufacturing and product development for the life sciences community.